Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study

SAT Study Group

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Understanding the level of patients' satisfaction with treatment and its determinants have the potential to impact therapeutic management and clinical outcome in chronic conditions such as chronic obstructive pulmonary disease (COPD). METHODS: A national, multicenter, longitudinal, observational study of COPD from 20 Italian pulmonary centers to explore patients' satisfaction to treatment [assessed by the Treatment Satisfaction Questionnaire, 9 items (TSQM-9)] and association with clinical parameters [including dyspnea score, COPD Assessment Test (CAT) score, exacerbation rate], adherence to treatment [Morisky Medication-Taking Adherence Scale (MMAS-4)], illness perception [evaluated by Brief Illness Perception Questionnaire (B-IPQ)] in a 1-year follow up. RESULTS: A total of 401 COPD patients were enrolled [69.4% group B Global Initiative for COPD (GOLD), considering 366 patients with available GOLD 2017 classification at enrollment]. At enrollment, satisfaction with treatment was moderate, being TSQM-9 mean scores for effectiveness 64.2 [95% confidence interval (CI) 62.5-65.9], for convenience 75.8 (95% CI 74.2-77.3), and for global satisfaction 65.7 (95% CI 64.0-67.4). Global satisfaction was negatively associated with disease perception (β = -0.4709, p < 0.0001), and grade of dyspnea (β = -4.2564, p = 0.009). Satisfaction with treatment was lower in patients with poor compared with optimal adherence to treatment (β = -4.5608, p = 0.002). Changes in inhalation regimens during follow up did not modify the satisfaction with treatment. CONCLUSIONS: The results of this real-life study showed that the patients' satisfaction with treatments is only moderate in COPD. A high grade of patients' satisfaction is associated mainly with a low perception of the disease, high adherence to treatment and lower level of dyspnea. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT02689492 The reviews of this paper are available via the supplemental material section.

Original languageEnglish
Pages (from-to)1753466619888128
JournalTherapeutic Advances in Respiratory Disease
Volume13
DOIs
Publication statusPublished - Jan 1 2019

Keywords

  • adherence
  • COPD
  • treatment satisfaction

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pharmacology (medical)

Cite this

Satisfaction with chronic obstructive pulmonary disease treatment : results from a multicenter, observational study. / SAT Study Group.

In: Therapeutic Advances in Respiratory Disease, Vol. 13, 01.01.2019, p. 1753466619888128.

Research output: Contribution to journalArticle

@article{0636a949e0634dc5bac9486185639559,
title = "Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study",
abstract = "BACKGROUND: Understanding the level of patients' satisfaction with treatment and its determinants have the potential to impact therapeutic management and clinical outcome in chronic conditions such as chronic obstructive pulmonary disease (COPD). METHODS: A national, multicenter, longitudinal, observational study of COPD from 20 Italian pulmonary centers to explore patients' satisfaction to treatment [assessed by the Treatment Satisfaction Questionnaire, 9 items (TSQM-9)] and association with clinical parameters [including dyspnea score, COPD Assessment Test (CAT) score, exacerbation rate], adherence to treatment [Morisky Medication-Taking Adherence Scale (MMAS-4)], illness perception [evaluated by Brief Illness Perception Questionnaire (B-IPQ)] in a 1-year follow up. RESULTS: A total of 401 COPD patients were enrolled [69.4{\%} group B Global Initiative for COPD (GOLD), considering 366 patients with available GOLD 2017 classification at enrollment]. At enrollment, satisfaction with treatment was moderate, being TSQM-9 mean scores for effectiveness 64.2 [95{\%} confidence interval (CI) 62.5-65.9], for convenience 75.8 (95{\%} CI 74.2-77.3), and for global satisfaction 65.7 (95{\%} CI 64.0-67.4). Global satisfaction was negatively associated with disease perception (β = -0.4709, p < 0.0001), and grade of dyspnea (β = -4.2564, p = 0.009). Satisfaction with treatment was lower in patients with poor compared with optimal adherence to treatment (β = -4.5608, p = 0.002). Changes in inhalation regimens during follow up did not modify the satisfaction with treatment. CONCLUSIONS: The results of this real-life study showed that the patients' satisfaction with treatments is only moderate in COPD. A high grade of patients' satisfaction is associated mainly with a low perception of the disease, high adherence to treatment and lower level of dyspnea. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT02689492 The reviews of this paper are available via the supplemental material section.",
keywords = "adherence, COPD, treatment satisfaction",
author = "{SAT Study Group} and Marco Contoli and Paola Rogliani and {Di Marco}, Fabiano and Fulvio Braido and Corsico, {Angelo G.} and Amici, {Christian A.} and Roberto Piro and Riccardo Sarzani and Patrizia Lessi and Carla Scognamillo and Nicola Scichilone and Pierachille Santus",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1753466619888128",
language = "English",
volume = "13",
pages = "1753466619888128",
journal = "Therapeutic Advances in Respiratory Disease",
issn = "1753-4658",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Satisfaction with chronic obstructive pulmonary disease treatment

T2 - results from a multicenter, observational study

AU - SAT Study Group

AU - Contoli, Marco

AU - Rogliani, Paola

AU - Di Marco, Fabiano

AU - Braido, Fulvio

AU - Corsico, Angelo G.

AU - Amici, Christian A.

AU - Piro, Roberto

AU - Sarzani, Riccardo

AU - Lessi, Patrizia

AU - Scognamillo, Carla

AU - Scichilone, Nicola

AU - Santus, Pierachille

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BACKGROUND: Understanding the level of patients' satisfaction with treatment and its determinants have the potential to impact therapeutic management and clinical outcome in chronic conditions such as chronic obstructive pulmonary disease (COPD). METHODS: A national, multicenter, longitudinal, observational study of COPD from 20 Italian pulmonary centers to explore patients' satisfaction to treatment [assessed by the Treatment Satisfaction Questionnaire, 9 items (TSQM-9)] and association with clinical parameters [including dyspnea score, COPD Assessment Test (CAT) score, exacerbation rate], adherence to treatment [Morisky Medication-Taking Adherence Scale (MMAS-4)], illness perception [evaluated by Brief Illness Perception Questionnaire (B-IPQ)] in a 1-year follow up. RESULTS: A total of 401 COPD patients were enrolled [69.4% group B Global Initiative for COPD (GOLD), considering 366 patients with available GOLD 2017 classification at enrollment]. At enrollment, satisfaction with treatment was moderate, being TSQM-9 mean scores for effectiveness 64.2 [95% confidence interval (CI) 62.5-65.9], for convenience 75.8 (95% CI 74.2-77.3), and for global satisfaction 65.7 (95% CI 64.0-67.4). Global satisfaction was negatively associated with disease perception (β = -0.4709, p < 0.0001), and grade of dyspnea (β = -4.2564, p = 0.009). Satisfaction with treatment was lower in patients with poor compared with optimal adherence to treatment (β = -4.5608, p = 0.002). Changes in inhalation regimens during follow up did not modify the satisfaction with treatment. CONCLUSIONS: The results of this real-life study showed that the patients' satisfaction with treatments is only moderate in COPD. A high grade of patients' satisfaction is associated mainly with a low perception of the disease, high adherence to treatment and lower level of dyspnea. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT02689492 The reviews of this paper are available via the supplemental material section.

AB - BACKGROUND: Understanding the level of patients' satisfaction with treatment and its determinants have the potential to impact therapeutic management and clinical outcome in chronic conditions such as chronic obstructive pulmonary disease (COPD). METHODS: A national, multicenter, longitudinal, observational study of COPD from 20 Italian pulmonary centers to explore patients' satisfaction to treatment [assessed by the Treatment Satisfaction Questionnaire, 9 items (TSQM-9)] and association with clinical parameters [including dyspnea score, COPD Assessment Test (CAT) score, exacerbation rate], adherence to treatment [Morisky Medication-Taking Adherence Scale (MMAS-4)], illness perception [evaluated by Brief Illness Perception Questionnaire (B-IPQ)] in a 1-year follow up. RESULTS: A total of 401 COPD patients were enrolled [69.4% group B Global Initiative for COPD (GOLD), considering 366 patients with available GOLD 2017 classification at enrollment]. At enrollment, satisfaction with treatment was moderate, being TSQM-9 mean scores for effectiveness 64.2 [95% confidence interval (CI) 62.5-65.9], for convenience 75.8 (95% CI 74.2-77.3), and for global satisfaction 65.7 (95% CI 64.0-67.4). Global satisfaction was negatively associated with disease perception (β = -0.4709, p < 0.0001), and grade of dyspnea (β = -4.2564, p = 0.009). Satisfaction with treatment was lower in patients with poor compared with optimal adherence to treatment (β = -4.5608, p = 0.002). Changes in inhalation regimens during follow up did not modify the satisfaction with treatment. CONCLUSIONS: The results of this real-life study showed that the patients' satisfaction with treatments is only moderate in COPD. A high grade of patients' satisfaction is associated mainly with a low perception of the disease, high adherence to treatment and lower level of dyspnea. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT02689492 The reviews of this paper are available via the supplemental material section.

KW - adherence

KW - COPD

KW - treatment satisfaction

UR - http://www.scopus.com/inward/record.url?scp=85075507920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075507920&partnerID=8YFLogxK

U2 - 10.1177/1753466619888128

DO - 10.1177/1753466619888128

M3 - Article

C2 - 31760881

AN - SCOPUS:85075507920

VL - 13

SP - 1753466619888128

JO - Therapeutic Advances in Respiratory Disease

JF - Therapeutic Advances in Respiratory Disease

SN - 1753-4658

ER -